Literature DB >> 23782298

Hard palate hyperpigmentation secondary to chronic chloroquine therapy: report of five cases.

Bruno Augusto Benevenuto de Andrade1, Felipe Paiva Fonseca, Fábio Ramôa Pires, Ana Terezinha Marques Mesquita, Saulo Gabriel Moreira Falci, Alan Roger Dos Santos Silva, Pablo Agustin Vargas, Jacks Jorge, Oslei Paes de Almeida.   

Abstract

Antimalarials are commonly prescribed in medical practice for conditions such as rheumatoid arthritis, lupus erythematosus, as well as malaria. They are generally well-tolerated, but side effects, although infrequent, are well known. The antimalarial chloroquine diphosphate may be associated with a bluish-gray to black hyperpigmentation of the oral mucosa, mainly on the hard palate. In this report we described five additional cases of palate hyperpigmentation related to the chronic use of chloroquine diphosphate. Professionals must be aware of the adverse effects of antimalarials as chloroquine diphosphate in order to make the correct diagnosis and appropriate management of the patient. Early diagnosis of oral pigmentation by antimalarials may be of great relevance, because it might be an early sign of ocular involvement, and therefore it may be helpful to prevent further complications of antimalarial therapy for the patient.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adverse reaction; antimalarial; chloroquine; hard palate; hyperpigmentation

Mesh:

Substances:

Year:  2013        PMID: 23782298     DOI: 10.1111/cup.12182

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  5 in total

Review 1.  Medication-Induced Oral Hyperpigmentation: A Systematic Review.

Authors:  Nada O Binmadi; Maram Bawazir; Nada Alhindi; Hani Mawardi; Ghada Mansour; Sana Alhamed; Sarah Alfarabi; Sara Akeel; Soulafa Almazrooa
Journal:  Patient Prefer Adherence       Date:  2020-10-15       Impact factor: 2.711

2.  Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules.

Authors:  O Ferraris; M Moroso; O Pernet; S Emonet; A Ferrier Rembert; G Paranhos-Baccalà; C N Peyrefitte
Journal:  Antiviral Res       Date:  2015-03-20       Impact factor: 5.970

3.  Oral pigmented lesions: a retrospective analysis from Brazil.

Authors:  D-M Albuquerque; J-L Cunha; A-L Roza; L-P Arboleda; A-R Santos-Silva; M-A Lopes; P-A Vargas; J Jorge; O-P de Almeida; A-C Abrahão; M Agostini; M-J Romañach
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2021-05-01

4.  Hyperpigmentation of hard palate induced by chloroquine therapy.

Authors:  Bruno-Augusto-Benevenuto de Andrade; Nelson-Alejandro Padron-Alvarado; Edgar-Manuel Muñoz-Campos; Thayná-Melo-de Lima Morais; Ricardo Martinez-Pedraza
Journal:  J Clin Exp Dent       Date:  2017-12-01

5.  Extensive hard palate hyperpigmentation associated with chloroquine use.

Authors:  Géssica Vasconcelos Godinho; Ana Luiza Lima Medeiros Paz; Elâine Patrícia Alves de Araújo Gomes; Cristiane Loreda Garcia; Luiz Evaristo Ricci Volpato
Journal:  Br J Clin Pharmacol       Date:  2020-04-20       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.